Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 20/09/2011
PIL TORISEL 30 mg concentrate and diluent for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 11/07/2011 and displayed until 20/09/2011
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 02/02/2011 and displayed until 11/07/2011
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to warnings or special precautions for use
Updated on 23/12/2010 and displayed until 02/02/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/07/2010 and displayed until 23/12/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 02/02/2010 and displayed until 14/07/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 15/01/2010 and displayed until 02/02/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 10/09/2009 and displayed until 15/01/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 26/03/2009 and displayed until 10/09/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 14/01/2009 and displayed until 26/03/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
Updated on 15/10/2008 and displayed until 14/01/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  temsirolimus